A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GB1211 in Healthy Subjects and in Subjects With Suspected Non-Alcoholic Steato-Hepatitis (NASH) and Liver Fibrosis

Condition:   Safety and Tolerability Interventions:   Drug: GB1211;   Drug: Placebo Sponsor:   Galecto Biotech AB Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials